Therapeutic Goods (Poisons Standard) (Benzylpenicillin—Seqirus) Approval 2024
Published
Related content
- Therapeutic Goods (Poisons Standard) (Benzylpenicillin - Seqirus) Exemption 2022This labelling exemption is granted under section 1.1(3) of Part 2 of the current Poisons Standard.
- Therapeutic Goods (Poisons Standard) (COVID-19 Vaccine-Pfizer) (Raxtozinameran) Labelling Exemption 2023We've granted a labelling exemption for the COVID-19 Vaccine, Pfizer (raxtozinameran), under the current Poisons Standard.
- Therapeutic Goods (Poisons Standard) (COVID-19 Vaccine - Moderna) (Elasomeran) Labelling Exemption 2022This labelling exemption is granted under section 1.5.5 of Part 2 of the current Poisons Standard.